ClinicalTrials.gov record
Codex: Study of Inodiftagene Vixteplasmid (BC-819) in Unresponsive NMIBC
ClinicalTrials.gov ID: NCT03719300
Public ClinicalTrials.gov record NCT03719300. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 2 Study of BC-819 in Patients With Non-Muscle Invasive Bladder Cancer Whose Disease is Unresponsive to Bacillus Calmette-Guerin
Study identification
- NCT ID
- NCT03719300
- Recruitment status
- Terminated
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- Anchiano Therapeutics Israel Ltd.
- Industry
- Enrollment
- 32 participants
Conditions and interventions
Conditions
Interventions
- inodiftagene vixteplasmid Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Mar 19, 2019
- Primary completion
- Nov 17, 2019
- Completion
- Dec 17, 2019
- Last update posted
- Aug 18, 2020
2019
United States locations
- U.S. sites
- 48
- U.S. states
- 26
- U.S. cities
- 43
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Alaska Urological Institute | Anchorage | Alaska | 99503 | — |
| Banner MD Anderson Cancer Center | Gilbert | Arizona | 85234 | — |
| Mayo Clinic Arizona | Phoenix | Arizona | 85054 | — |
| Urological Associates of Southern Arizona | Tucson | Arizona | 85715 | — |
| Arkansas Urology | Little Rock | Arkansas | 72211 | — |
| American Institute of Research | Los Angeles | California | 90017 | — |
| UC Davis Medical Center | Sacramento | California | 95817 | — |
| The Urology Center of Colorado | Denver | Colorado | 80211 | — |
| Mayo Clinic Florida | Jacksonville | Florida | 32224 | — |
| University of Florida Health Jacksonville, Shands Hospital | Jacksonville | Florida | 33209 | — |
| Emory University | Atlanta | Georgia | 30322 | — |
| North Idaho Urology | Coeur d'Alene | Idaho | 83814 | — |
| Idaho Urologic Institute, PA | Meridian | Idaho | 83642 | — |
| University of Illinois Hospital and Health Systems (Outpatient Care Center) | Chicago | Illinois | 60612 | — |
| The University of Kansas Cancer Center | Westwood | Kansas | 66205 | — |
| Wichita Urology Group | Wichita | Kansas | 67226 | — |
| Tulane University School of Medicine | New Orleans | Louisiana | 70114 | — |
| Ochsner Clinical Foundation | New Orleans | Louisiana | 70121 | — |
| Johns Hopkins Medical Institution | Baltimore | Maryland | 21287 | — |
| Spectrum Health Medical Group | Grand Rapids | Michigan | 49546 | — |
| Michigan Institute of Urology, PC | Troy | Michigan | 48084 | — |
| Mayo Clinic | Rochester | Minnesota | 55905 | — |
| Saint Louis University | St Louis | Missouri | 63110 | — |
| Washington University | St Louis | Missouri | 63110 | — |
| New Jersey Urology, LLC | Belleville | New Jersey | 08043 | — |
| MD Anderson Cancer Center at Cooper | Voorhees Township | New Jersey | 08103 | — |
| Albany Medical College | Albany | New York | 12208 | — |
| Weill Cornell Medical College - NY Presbyterian Hospital | New York | New York | 10065 | — |
| SUNY Upstate Medical University | Syracuse | New York | 13210 | — |
| Montefiore Medical Center | The Bronx | New York | 10461 | — |
| UNC Chapel Hill Hospital, Urology Clinic | Chapel Hill | North Carolina | 27514 | — |
| Duke University | Durham | North Carolina | 27710 | — |
| Alliance Urology Specialists, PA | Greensboro | North Carolina | 27403 | — |
| Carolina Urology Partners, PLLC | Huntersville | North Carolina | 28078 | — |
| University of Toledo, Dept. of Urology and Kidney Transplant | Toledo | Ohio | 43614 | — |
| University of Oklahoma Health Sciences Center | Oklahoma City | Oklahoma | 73104 | — |
| MidLantic Urology | Bala-Cynwyd | Pennsylvania | 19004 | — |
| The Hospital of the University of Pennsylvania | Philadelphia | Pennsylvania | 19104 | — |
| Medical University South Carolina | Charleston | South Carolina | 29425 | — |
| Regional Urology | Greenville | South Carolina | 29605 | — |
| Urology Associates, P.C. | Nashville | Tennessee | 37209 | — |
| University of Texas Southwestern Medical Center | Dallas | Texas | 75390 | — |
| Baylor College of Medicine Medical Center | Houston | Texas | 77030 | — |
| The Methodist Hospital d/b/a Houston Methodist Hospital | Houston | Texas | 77030 | — |
| The University of Texas MD Anderson Cancer Center | Houston | Texas | 77030 | — |
| Virginia Urology | Richmond | Virginia | 23235 | — |
| Urology of Virginia | Virginia Beach | Virginia | 23462 | — |
| West Virginia University Cancer Institute | Morgantown | West Virginia | 26506 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT03719300, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Aug 18, 2020 · Synced Jul 23, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT03719300 live on ClinicalTrials.gov.